SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories - Quaterly Results

13 Feb 2023 Evaluate
The Revenue for the quarter ended  December 2022 of Rs. 2692.50 millions grew by 13.86 % from Rs. 2364.70 millions.Net Profit witnessed a 139.07% growth almost the double from Rs. 127.31 millions to Rs. 304.36  millions  of same quarter last year.OP of the company witnessed a marginal growth to 548.77 millions from 341.94 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 2692.50 2364.70 13.86 7841.26 6952.05 12.79 9510.77 9369.13 1.51
Other Income 9.33 19.00 -50.89 16.84 42.43 -60.31 20.77 160.95 -87.10
PBIDT 548.77 341.94 60.49 1532.76 1049.27 46.08 1442.70 1625.38 -11.24
Interest 27.45 33.22 -17.37 87.78 107.25 -18.15 134.94 178.98 -24.61
PBDT 521.32 308.72 68.86 1444.98 942.02 53.39 1307.76 1446.40 -9.59
Depreciation 133.36 127.75 4.39 393.06 365.85 7.44 490.36 396.78 23.58
PBT 387.96 180.97 114.38 1051.92 576.17 82.57 817.40 1049.62 -22.12
TAX 83.60 53.66 55.80 265.81 159.12 67.05 182.06 246.67 -26.19
Deferred Tax 17.38 9.23 88.30 15.27 25.20 -39.40 -22.16 121.84 -118.19
PAT 304.36 127.31 139.07 786.11 417.05 88.49 635.34 802.95 -20.87
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.00 129.00 0.00
PBIDTM(%) 20.38 14.46 40.95 19.55 15.09 29.51 15.17 17.35 -12.56

Neuland Laboratories Share Price

17211.95 212.20 (1.25%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: